Photobiomodulation Therapy (PBMT)- the use of emitting non-ionizing, non-thermal light photons (usually red light and near Infrared light) directly into the target tissue to create a photochemical cellular reaction that produces a multitude of beneficial therapeutic outcomes including but not limited to Analgesic, Anti-Inflammatory, Increased Blood Flow, Accelerated Healing, and Cell Regeneration.
PHOTOBIOMODULATION THERAPEUTIC BENEFITS
- Similar to acetaminophen, pain receptors (nerves) are temporarily disrupted, blocking pain signals to the brain
Anti-Inflammatory - Oxidative stress, the main component of acute and chronic inflammation, is
reduced. Adenosine Triphosphate (ATP)
is increased in the cell tissue while Nitric Oxide is released, restoring
normal cell function and increasing local circulation
Increased Blood Flow - induces arterial vasodilation resulting in an increase in capillary flow and tissue perfusion at the treated area
Accelerated Healing - Fibroblast proliferation and collagen synthesis are increased allowing
faster cellular tissue reconnection and repair
Cell Regeneration - Cell proliferation and differentiation are increased in the target cell tissue
*While many clinical studies have shown positive results, no medical claims are being made other than for those issues such as pain and inflammation, for a specific laser that has been cleared for such by the FDA.
Commonly Treated Dental Conditions
Include but are not limited to...
Bleeding - Tissue Coagulation
Healing Pain Reduction
Commonly Treated Animal Conditions
Include but are not limited to...
CLINICAL CASE STUDIES
An Overview of Photobiomodulation or Low-Level Laser Therapy on Musculoskeletal Pain, its biochemical process, condition list, and dose metrics. [R]
A detailed explanation of Photobiomodulation or Low-Level Laser Therapy's cellular anti-inflammatory reaction and clinical application [R]
A 2022 report on the evidence of Photobiomodulation or Low-Level Laser Therapy's effect on common ligament, cartilage, and tendon conditions. [R]
A parallel study that evaluated the benefits of Photobiomodulation or Low-Level Laser Therapy with a qualitative comparison of analgesic pharmacotherapy.
A 2022 in vitro study explored Photobiomodulation or Low-Level Laser Therapy's effect on cell viability and proliferation of fibroblast cells. [R]
A 2019 Meta-Analysis review of published clinical trials found Photobiomodulation or Low-Level Laser Therapy' is an effective, safe, and well-tolerated treatment for Fibromyalgia. [R]
Fatty Liver Disease
A 2021 study compared the benefits of Photobiomodulation or Low-Level Laser Therapy and a Mediterranean diet vs only a Mediterranean diet to treat older adults with non-alocoholic fatty livers. [R]
A 2019 meta-analysis review of Photobiomodulation or Low-Level Laser Therapy effects on knee osteoarthritis pain and disability. [R]
A 2018 Meta-Analysis on Photobiomodulation or Low-Level Laser Therapy effects on Temporomandibular Disorder in published clinical studies with randomized controlled trials. [R]
A 2022 published case study of a 64-year-old man with grade 3 oral mucositis who was treated with Photobiomodulation or Low Level Laser Therapy. [R]
A 2021 randomized double-blind placebo-controlled study that evaluated the effects of Photobiomodulation or Low-Level Laser Therapy on Allergic Rhinitis [R]
Enhances proliferation of immune cells (enhancement of immune response, increase of Sodium Potassium (NK) cell activity etc.
Enhances lymphatic activity (drainage)
Improves microcirculation (vasodilation)
Reduces swelling (oedema & haematoma resorption)
Reduces infarct zone size in heart & brain
Reduces mucositis after irradiation & chemotherapy